Deraya University Report issue

Academic/Hospital Phase 1 Phase 2

Organization Overview

First Clinical Trial
2020
NCT04657809
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Deraya University | faculty of pharmacy, Deraya university | Soad Ali

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Olfaction Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 7